What is the share price of Procter & Gamble Health
Limited?
Get PGHL share value with Latest News, Volume
Breakout, Delivery Volume Percentage, Pivot Levels,
Fibonacci Levels, Camarilla levels and Candlestick
Patterns. Company shares prices keep fluctuating as
per market conditions. There may be many reasons for
the rise and fall of the share price of stocks. It may
be market conditions, it may be sector & industry
reasons and it may be stocks itself like earnings,
order, upgrade or downgrade etc. PGHL share
value today is ₹4735.4
24 Apr, 2024 | 03:32PM
What is the Market cap of Procter & Gamble Health
Limited?
The Market Cap of
Procter & Gamble Health Limited is
₹7860 Cr As on
24 Apr, 2024 | 03:32PM. Market capitalization,
or market cap, is the total value of a company's
shares of stock. It is one measurement of a company's
size. A high market cap signifies that the company has
a larger presence in the market. Larger companies may
have less growth potential compares to start-up firms.
Market capitalization refers to how much a company is
worth as determined by the stock market. It is defined
as the total market value of all outstanding shares.
To calculate a company's market cap, multiply the
number of outstanding shares by the current market
value of one share.
What is the PE ratio of Procter & Gamble Health
Limited?
The P/E ratio of
Procter & Gamble Health Limited is
34.62 As on
24 Apr, 2024 | 03:32PM. Price to Earnings Ratio
or Price to Earnings Multiple is the ratio of share
price of a stock to its earnings per share (EPS). PE
ratio is one of the most popular valuation metric of
stocks. Typically, the average P/E ratio is around 20
to 25. In general, a high P/E suggests that investors
are expecting higher earnings growth in the future
compared to companies with a lower P/E. A low P/E can
indicate either that a company may currently be
undervalued or that the company growth has stagnant
due to its matured stage.
What is the 52-week high and 52-week low of Procter &
Gamble Health Limited?
A 52 week high of
Procter & Gamble Health Limited is
₹5642.85 while 52 week low is ₹4575. A
52 week high, as the name suggests, is the highest
price that the security/stock has traded over a 52
week period i.e. a year. Similarly 52 week low is the
lowest price that stock has traded over a 52 week
period. It is a technical indicator that is used to
analyse the security's current price. The 52 week high
and 52 week low are also used to predict future
movements as well. 52 week is bullish signal and 52
week low is bearish signal.
What is Support price of Procter & Gamble Health
Limited?
First support of
Procter & Gamble Health Limited is
₹4662.73
Second support of
Procter & Gamble Health Limited is
₹4619.92
Third support of
Procter & Gamble Health Limited is
₹4538.78
Traders use support to plan
entry. Support is the level at which demand is strong
enough to stop the stock from falling any further.
Support is specific point on chart at which maximum
buiying occurs.
What is Resistance price of Procter & Gamble Health
Limited?
First resistance of
Procter & Gamble Health Limited is
₹4786.68
Second resistance of
Procter & Gamble Health Limited is
₹4867.82
Third resistance of
Procter & Gamble Health Limited is
₹4910.63
Traders use resistance to plan
exit of trade. Resistance is the level at which
selling is strong enough to stop the stock from moving
up any further. Resistance is specific point on chart
at which maximum selling occurs.
What is Procter & Gamble Health Limited share price
target 2024?
First target of
Procter & Gamble Health Limited is
₹5042.90
Second target of
Procter & Gamble Health Limited is
₹5379.80
Third target of
Procter & Gamble Health Limited is
₹5573.55
What is Procter & Gamble Health Limited share price
target 2025?
First target of Procter & Gamble Health Limited is
₹6666.48
Second target of
Procter & Gamble Health Limited is
₹6914.21
Third target of
Procter & Gamble Health Limited is
₹7345.85
What is Procter & Gamble Health Limited share price
history?
Date |
Open |
High |
Low |
Close |
Volume |
%Chg |
2024-04-22 |
4718.2 |
4747.9 |
4675.15 |
4701.1 |
6568 |
0.2 |
2024-04-19 |
4675 |
4712 |
4642.55 |
4694.7 |
8445 |
-0.12 |
2024-04-18 |
4702 |
4749.15 |
4675 |
4700.5 |
9099 |
-0.71 |
2024-04-16 |
4687.25 |
4749.8 |
4666.5 |
4734.75 |
6047 |
0.92 |
2024-04-15 |
4751 |
4765 |
4646 |
4687.25 |
13464 |
-1.84 |
2024-04-12 |
4815 |
4835.9 |
4752.05 |
4777.1 |
5063 |
-0.66 |
2024-04-10 |
4826.4 |
4839.9 |
4757.55 |
4806.8 |
4995 |
-0.37 |
2024-04-08 |
4752.1 |
4812.8 |
4750 |
4783.45 |
9835 |
0.56 |
2024-04-05 |
4800.05 |
4800.05 |
4733.6 |
4763.15 |
9775 |
0.06 |
2024-04-04 |
4797 |
4798.7 |
4740 |
4771.45 |
6664 |
0.5 |
Historical share price of stock is needed to find
the trend of stock, performance analysis of stock
price. History of share price is also used to find
the demand and supply by analyzing volume data if
available.
What is the ROE (Return on Equity) of Procter & Gamble
Health Limited?
The ROE of Procter & Gamble Health Limited is
33.56% . Return on equity (ROE) is the measure
of a company's net income divided by its shareholders'
equity. ROE is a gauge of a corporation's
profitability and how efficiently it generates those
profits. The higher the ROE, the better a company. A
return on equity ratio of 15% to 20% is usually
considered good. ROE is a gauge of a corporation's
profitability and how efficiently it generates those
profits.
What is the Earning per Share (EPS) of Procter &
Gamble Health Limited?
The EPS of Procter & Gamble Health Limited is
₹136.55. Earnings per share (EPS) is a
company's net profit divided by the number of common
shares it has outstanding. EPS indicates how much
money a company makes for each share of its stock.
There's no fixed answer for what is a good EPS. When
comparing companies, it's helpful to look closely at
how EPS is trending and how it matches up to
competitor earnings. Remember that a higher EPS can
suggest growth and stock price increases.
What is the ROCE of Procter & Gamble Health Limited?
The ROCE of Procter & Gamble Health Limited is
39.51%. Return on capital employed is a
financial ratio that measures a company's
profitability in terms of all of its capital. ROCE is
similar to return on invested capital. It's always a
good idea to compare the ROCE of companies in the same
industry. The higher the ROCE, the better it is. The
ratio calculated as 20% is considered good, indicating
the company is more profitable and has a stable
financial position in the market.
What is the NPM (Net profit margin) of Procter &
Gamble Health Limited?
The NPM of Procter & Gamble Health Limited is
18.39%. Net Profit Margin is a financial ratio
used to calculate the percentage of profit a company
produces from its total revenue. Net profit margin
helps investors assess if a company's management is
generating enough profit from its sales and whether
operating costs and overhead costs are under control.
What is EBITDA of Procter & Gamble Health Limited?
The EBITDA of
Procter & Gamble Health Limited is
27.49%. EBITDA stands for Earnings Before
Interest, Taxes, Depreciation, and Amortization. It is
the alternate method of measuring profitability in net
income. EBITDA is useful when comparing companies with
different capital investment, debt, and tax
profiles.This key profitability measure is one of the
main measures of a company's financial health and
ability to generate cash. It is one of the most widely
used measures of a company's financial health and
ability to generate cash.
What is Debt to Equity ratio (D/E Ratio) of Procter &
Gamble Health Limited?
The debt to equity ratio of
Procter & Gamble Health Limited is 1.60.
The debt-to-equity ratio (D/E ratio) shows how much
debt a company has compared to its assets. It is found
by dividing a company's total debt by total
shareholder equity. Generally, a good debt to equity
ratio is around 1 to 1.5. However, the ideal debt to
equity ratio will vary depending on the industry, as
some industries use more debt financing than others. A
higher D/E ratio means the company may have a harder
time covering its liabilities. It will be very hard if
the economic scenario worsens.
What is Procter & Gamble Health Limited news today?
Procter & Gamble Health Limited share news
: LTP 4735.4
%Chg: 0.19
Chg: 9
Volume: 3296
Get detailed Procter & Gamble Health Limited share
price news, analysis, Dividend, Quarterly results,
Fundamentals & more information.
Today’s Procter & Gamble Health Limited screener scan?
Get the last 5 days of Procter & Gamble Health Limited
share screener at "ALL SCAN" feature of Money Tree
Robo with recommended price for buying & selling. Also
find the trend of Procter & Gamble Health Limited
share price screener after recommendation.
What is Procter & Gamble Health Limited share price
target?
Procter & Gamble Health Limited share price target
today:
First target of Procter & Gamble Health Limited
share is ₹4850.15.
Second target of Procter & Gamble Health Limited
share is ₹4860.49.
Third target of Procter & Gamble Health Limited
share is ₹4891.48.